One Piece is currently on a rare months-long break, which means there's never been a better time to watch One Piece in order. But it's an intimidating ask to dive right in: after all, it stands alone ...

When it premiered in the summer of 2023, Netflix's live-action adaptation of One Piece took the world by storm, so, of course, the countdown for One Piece season 2 has been on ever since. Well, now ...

Iowans living in or near the path of proposed carbon pipelines have rallied at the Statehouse during past legislative sessions to support a bill that would restrict the use of eminent domain for such ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Each organization that owns a domain, such as google.com, is responsible for maintaining its own DNS entries in its own DNS server. When your device needs to find an IP address, it asks a DNS server, ...

It's the end of an era for ongoing anime, as Toei Animation announces a new production schedule for One Piece, which has been an ongoing series for a quarter-century, spanning over a dozen filler arcs ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...